Martin Gramatzki
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 32
- Immunology top 0.5%
- T-cell and B-cell Immunology 30
- Immune Cell Function and Interaction 28
- Oncology top 1%
- CAR-T cell therapy research 34
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 39
-
- Lymphoma Diagnosis and Treatment 42
-
- Monoclonal and Polyclonal Antibodies Research 65
-
- Glycosylation and Glycoproteins Research 20
- Co-authors
- Renate BurgerRoland ReppThomas ValeriusMatthias PeippBernhard StockmeyerJan G. J. van de WinkelChristian KellnerE Platzer
- Cited by
- HematologyImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (22 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Martin Gramatzki
204 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 1.8k
- Immunology 2.6k
- Oncology 2.5k
- Genetics 844
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Martin Gramatzki
This map shows the geographic impact of Martin Gramatzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Gramatzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Gramatzki more than expected).
Fields of papers citing papers by Martin Gramatzki
This network shows the impact of papers produced by Martin Gramatzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Gramatzki. The network helps show where Martin Gramatzki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Gramatzki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 10 | |
| 3 | 2021 | 4 | |
| 4 | 2018 | 80 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 26 | |
| 7 | 2017 | 22 | |
| 8 | 2015 | 31 | |
| 9 | 2014 | 126 | |
| 10 | 2011 | 38 | |
| 11 | Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancerbreakdown → | 2007 | 524 |
| 12 | 2007 | 330 | |
| 13 | Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma. | 2006 | 3 |
| 14 | 2004 | 3 | |
| 15 | 2004 | 96 | |
| 16 | 2003 | 33 | |
| 17 | The addition of rituximab to combination chemotherapy with fludarabine, cyclophosphamide, mitoxantrone (FCM) results in a significant increase of overall response as compared to FCM alone in patients with relapsed or refractory follicular (FCL) and mantel cell lymphomas (MCL) - Results of a prospective randomized comparison of the German low grade study group (GLSG). | 2001 | 0 |
| 18 | 2000 | 98 | |
| 19 | 1997 | 18 | |
| 20 | 1993 | 25 |
About Martin Gramatzki
Martin Gramatzki is a scholar working on Hematology, Genetics and Immunology, having authored 207 papers that have together received 6.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (65 papers), Lymphoma Diagnosis and Treatment (42 papers), Chronic Lymphocytic Leukemia Research (39 papers), CAR-T cell therapy research (34 papers), Multiple Myeloma Research and Treatments (32 papers), T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (28 papers) and Glycosylation and Glycoproteins Research (20 papers). The work is most often cited by research in Hematology (1.8k citations), Immunology (2.6k citations) and Oncology (2.5k citations). Martin Gramatzki has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Renate Burger, Roland Repp, Thomas Valerius, Matthias Peipp, Bernhard Stockmeyer, Jan G. J. van de Winkel, Christian Kellner, E Platzer, Joachim R. Kalden and Friedemann Horn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.